<div class="modal fade in" id="HistoryModal" role="dialog" style="display: block;">
  <div class="modal-dialog" role="document">
    <div class="modal-content">
            <div class="modal-header bg-primary">
        <button type="button" class="close" data-dismiss="modal">Ã—</button>
        <h5 class="modal-title">HOUSE BILL/RESOLUTION HISTORY</h5>
      </div>
      <div class="modal-body">
        <div class="fetched-data"><table width="auto" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="3">House Bill/Resolution NO. <b>HB01150</b></td></tr><tr><td colspan="3">FULL TITLE : AN ACT ESTABLISHING A DRUG REHABILITATION CENTER IN THE MUNICIPALITY OF PILI, IN THE PROVINCE OF CAMARINES SUR, TO BE KNOWN AS THE CAMARINES SUR DRUG REHABILITATION CENTER AND ALLOCATING FUNDS THEREFOR, AND FOR OTHER PURPOSES</td></tr><tr><td colspan="3">SHORT TITLE : Establishing A Drug Rehabilitation Center In The Municipality Of Pili, In The Province Of Camarines Sur, To Be Known As The Camarines Sur Drug Rehabilitation Center</td></tr><tr><td colspan="3">PRINCIPAL AUTHOR/S : <b>VILLAFUERTE, LUIS R.</b></td></tr><tr><td colspan="3">DATE FILED : 2010-07-08</td></tr><tr><td colspan="3">SIGNIFICANCE: LOCAL</td></tr><tr><td colspan="3">CO-AUTHORS : </td></tr><tr><td width="33%">1. Belmonte (V.)</td></tr><tr><td colspan="3">CO-AUTHORS (Journal Entries) :</td></tr><tr><td>1. Co (009 )</td><td>2. Batocabe (009 )</td></tr><tr><td>3. Garbin (009 )</td></tr><tr><td colspan="3"><b>ACTIONS TAKEN BY THE COMMITTEE</b></td></tr><tr><td colspan="3">COMMITEE HEARINGS/ACTIONS:</td></tr><tr><td colspan="3"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Referred to stakeholders on 2010-08-25</b></td></tr><tr><td colspan="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-Referred to the Dangerous Drugs Board, Philippine Drug Enforcement Agency, Department of Health, PNP Anti Illegal Drugs Special Operations Task Force and the National Bureau of Investigation for comments and suggestions</td></tr><tr><td colspan="3"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Approved by the Committee on 2010-08-25</b></td></tr><tr><td colspan="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-Omnibus Approval for Transmittal to the Committee on Appropriations</td></tr><tr><td colspan="3"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Approved by the Committee on Appropriations on 2011-05-19</b></td></tr><tr><td colspan="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-Approved without amendment pursuant to Section 44 of the Rules of the House of Representatives, 15th Congress.</td></tr><tr><td colspan="3">COMMITTEE REPORT NO.&nbsp;01428</td></tr><tr><td colspan="3">SUBMITTED ON 2011-10-04</td></tr><tr><td colspan="3">SUBMITTED BY:&nbsp;DANGEROUS DRUGS</td></tr><tr><td colspan="3">RECOMMENDATIONS:&nbsp;approval with amendments</td></tr><tr><td colspan="3"><b>ACTIONS TAKEN BY THE COMMITTEE ON RULES</b></td></tr><tr><td colspan="3">REFERRAL TO THE COMMITTEE ON DANGEROUS DRUGS ON 2010-08-02</td></tr><tr><td colspan="3">DATE INCLUDED IN OB:&nbsp;2011-10-05</td></tr><tr><td colspan="3">BUSINESS FOR THU/FRI ON:&nbsp;2011-10-11</td></tr><tr><td colspan="3"><b>SECOND READING INFORMATION</b><br></td></tr><tr><td colspan="3">PERIOD OF SPONSORSHIP :&nbsp;2011-10-11</td></tr><tr><td colspan="3">PERIOD OF COMMITTEE AMENDMENTS :&nbsp;2011-10-11</td></tr><tr><td colspan="3">DATE APPROVED ON SECOND READING :&nbsp;2011-10-11</td></tr><tr><td colspan="3">REMARKS :&nbsp;Adopted the Explanatory Note as the sponsorship remarks.</td></tr><tr><td colspan="3"><b>THIRD READING INFORMATION</b></td></tr><tr><td colspan="3">DATE COPY DISTRIBUTED TO MEMBERS:&nbsp;2011-11-14</td></tr><tr><td colspan="3">DATE APPROVED BY THE HOUSE ON THIRD READING :2011-11-23</td></tr><tr><td>HOUSE VOTES:&nbsp;&nbsp;&nbsp;&nbsp;YEAS:192&nbsp;&nbsp;&nbsp;&nbsp; NAYS:0&nbsp;&nbsp;&nbsp;&nbsp;ABSTAIN:.0</td></tr><tr><td colspan="3">DATE TRANSMITTED TO THE SENATE: &nbsp;2011-11-29</td></tr><tr><td colspan="3"><b>ACTIONS TAKEN BY THE SENATE/HOUSE</b></td></tr><tr><td colspan="3">DATE RECEIVED BY THE SENATE: &nbsp;2011-11-29</td></tr><tr><td colspan="3">REMARKS :&nbsp;     </td></tr></tbody></table></div>
      </div>
      <div class="modal-footer">
        <a class="btn btn-default btn-success" data-dismiss="modal">Close</a>
      </div>
    </div>
  </div>
</div>